Tacstick Eye Ointment contains Tacrolimus 0.03% w/w, a topical immunomodulator and anti-inflammatory ophthalmic ointment used for immune-mediated ocular disorders, including vernal keratoconjunctivitis, chronic dry eye with inflammation, and ocular surface inflammation.
Tacrolimus works by inhibiting T-cell activation, reducing cytokine-mediated inflammation and preventing immune-mediated ocular tissue damage. The ointment formulation allows prolonged retention, ensuring enhanced therapeutic efficacy and patient comfort.
Clinically, Tacstick Eye Ointment helps in reducing redness, swelling, itching, and ocular irritation, supporting healing of inflamed ocular surfaces. It is ideal for patients with chronic inflammatory eye conditions who require safe, long-term management without the risks associated with steroids.
From a business perspective, Tacstick Eye Ointment strengthens the ophthalmic anti-inflammatory segment, widely used in eye hospitals, clinics, and specialty ophthalmology practices, providing consistent demand, reliable efficacy, and high patient satisfaction.